Skip to main content
. 2023 Jun;29(6):10.18553/jmcp.2023.29.6.607. doi: 10.18553/jmcp.2023.29.6.607

TABLE 3.

Frequency With Which Plans Impose Coverage Restrictions in Medical and Pharmacy Coverage Policies

Medical policies, n (%) Pharmacy policies, n (%) Total number of medical-pharmacy policy pairs
No restriction Any restriction(s)a Prescriber requirement Patient subgroup restriction Step therapy protocol Not covered No restriction Any restriction(s)a Prescriber requirement Patient subgroup restriction Step therapy protocol Not covered
Health plan
  Plan 1 46 (69) 14 (21) 1 (2) 2 (3) 13 (19) 7 (10) 46 (69) 14 (21) 1 (2) 2 (3) 13 (19) 7 (10) 67
  Plan 2 362 (59) 249 (41) 5 (.8) 64 (10) 209 (34) 2 (.3) 350 (57) 261 (43) 5 (.8) 64 (10) 222 (36) 2 (.3) 613
  Plan 3 204 (50) 202 (49) 1 (.2) 117 (28) 101 (25) 4 (1) 204 (50) 202 (49) 1 (.2) 116 (28) 102 (25) 4 (1) 410
  Plan 4 7 (28) 10 (40) 10 (40) 0 5 (20) 8 (32) 8 (32) 10 (40) 10 (40) 0 6 (24) 7 (28) 25
  Plan 5 173 (56) 123 (40) 3 (1) 23 (8) 110 (36) 12 (4) 183 (59) 115 (37) 3 (1) 19 (6) 104 (34) 10 (3) 308
  Plan 6 35 (34) 61 (59) 43 (41) 15 (14) 34 (33) 8 (8) 36 (35) 60 (58) 22 (21) 22 (21) 32 (31) 8 (8) 104
  Plan 7 34 (44) 32 (42) 0 8 (10) 28 (36) 11 (14) 35 (46) 34 (44) 18 (23) 9 (12) 24 (31) 8 (10) 77
  Plan 8 4 (27) 11 (73) 0 2 (13) 11 (73) 0 2 (13) 13 (87) 11 (73) 2 (13) 9 (60) 0 15
Cancer indication
  Yes 447 (74) 152 (25) 3 (.5) 78 (13) 72 (12) 2 (.3) 455 (75) 144 (24) 2 (.3) 80 (13) 65 (11) 2 (.3) 601
  No 418 (41) 550 (54) 60 (6) 153 (15) 439 (43) 50 (5) 409 (40) 565 (56) 69 (7) 154 (15) 447 (44) 44 (4) 1,018
Orphan drug designation
  Yes 416 (64) 230 (36) 28 (4) 124 (19) 120 (19) 2 (.3) 421 (65) 225 (35) 31 (5) 127 (20) 112 (17) 2 (.3) 648
  No 449 (46) 472 (49) 35 (4) 107 (11) 391 (40) 50 (5) 443 (46) 484 (50) 40 (4) 107 (11) 400 (41) 44 (5) 971
  Total 865 (53) 702 (43) 63 (4) 231 (14) 511 (32) 52 (3) 864 (53) 709 (44) 71 (4) 234 (14) 512 (32) 46 (3) 1,619

aPolicies may have more than 1 type of restriction, eg, prescriber requirement, patient subgroup restriction, and/or step therapy protocol.